Search research articles
Contact Us
Filters
Showing results (111-120 of 263) with videos related to
Page
of 27
Sort By:
Cardiovascular Research
|
March 1, 1981
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist
R H Falk, R D Desilva, B Lown
Cardiovascular Research
|
September 1, 1974
Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure
R L Verrier, P L Thompson, B Lown
Circulation
|
June 1, 1973
Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects
B Lown, J V Temte, W J Arter
Coeur Et Medecine Interne
|
October 1, 1972
[Clinical and experimental determination of the digitalization level]
B Lown, F Hagemeijer, I Barr, et al.
American Heart Journal
|
May 1, 1986
Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion
E A Raeder, R L Verrier, B Lown
American Heart Journal
|
August 1, 1982
Influence of the autonomic nervous system on coronary blood flow during partial stenosis
E A Raeder, R L Verrier, B Lown
The American Journal of Cardiology
|
February 1, 1981
Extra-adrenergic mechanisms responsible for the effects of glucose-insulin-potassium solution on vulnerability to ventricular fibrillation
W W Brooks, R L Verrier, B Lown
The New England Journal of Medicine
|
November 5, 1981
Prognosis of medically treated patients with coronary-artery disease with profound ST-segment depression during exercise testing
P J Podrid, T B Graboys, B Lown
Life Sciences
|
January 1, 1990
Epinephrine-induced decrease in repetitive extrasystole threshold is reversed by tyrosine in conscious dogs
J M Pinto, D A Kirby, B Lown
European Journal of Pharmacology
|
May 7, 1982
Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart
P R Kowey, R L Verrier, B Lown
Page
of 27
Search research articles
Search
Showing results (111-120 of 263) with videos related to
Sort By:
Page
of 27
Cardiovascular Research
|
March 1, 1981
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist
R H Falk, R D Desilva, B Lown
Cardiovascular Research
|
September 1, 1974
Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure
R L Verrier, P L Thompson, B Lown
Circulation
|
June 1, 1973
Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects
B Lown, J V Temte, W J Arter
Coeur Et Medecine Interne
|
October 1, 1972
[Clinical and experimental determination of the digitalization level]
B Lown, F Hagemeijer, I Barr, et al.
American Heart Journal
|
May 1, 1986
Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion
E A Raeder, R L Verrier, B Lown
American Heart Journal
|
August 1, 1982
Influence of the autonomic nervous system on coronary blood flow during partial stenosis
E A Raeder, R L Verrier, B Lown
The American Journal of Cardiology
|
February 1, 1981
Extra-adrenergic mechanisms responsible for the effects of glucose-insulin-potassium solution on vulnerability to ventricular fibrillation
W W Brooks, R L Verrier, B Lown
The New England Journal of Medicine
|
November 5, 1981
Prognosis of medically treated patients with coronary-artery disease with profound ST-segment depression during exercise testing
P J Podrid, T B Graboys, B Lown
Life Sciences
|
January 1, 1990
Epinephrine-induced decrease in repetitive extrasystole threshold is reversed by tyrosine in conscious dogs
J M Pinto, D A Kirby, B Lown
European Journal of Pharmacology
|
May 7, 1982
Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart
P R Kowey, R L Verrier, B Lown
Page
of 27